Conference Agenda

Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).

 
 
Session Overview
Session
Session 3: Dynamics within Neural Circuits
Time:
Thursday, 02/May/2024:
2:10pm - 3:30pm

Session Chair: Hanna Hörnberg
Location: MDC.C Axon 1


Show help for 'Increase or decrease the abstract text size'
Presentations
2:10pm - 2:40pm
ID: 131 / Session 3: 1
Talk

A trans-cellular signaling pathway for the control of neuronal excitation – inhibition balance

Peter Scheiffele

University of Basel, Switzerland

Our laboratory is exploring cell biological mechanisms underlying formation and plasticity of neuronal synapses in development, physiological states, and disorders. Throughout life, neuronal networks in the mammalian neocortex maintain a balance of excitation and inhibition which is essential for neuronal computation. Deviations from a balanced state have been linked to neurodevelopmental disorders and severe disruptions result in epilepsy. To maintain balance, neuronal microcircuits composed of excitatory and inhibitory neurons sense alterations in neural activity and adjust neuronal connectivity and function. Here, we identified a signaling pathway in the adult mouse neocortex that is activated in response to elevated neuronal network activity. Over-activation of excitatory neurons is signaled to the network through the elevation of BMP2, a growth factor well-known for its role as morphogen in embryonic development. BMP2 acts on parvalbumin-expressing (PV) interneurons through the transcription factor SMAD1, which controls an array of glutamatergic synapse proteins and components of peri-neuronal nets. PV interneuron-specific impairment of BMP2-SMAD1 signaling is accompanied by a loss of PV cell glutamatergic innervation, underdeveloped peri-neuronal nets, and decreased excitability. Ultimately, this impairment of PV interneuron functional recruitment disrupts cortical excitation – inhibition balance with mice exhibiting spontaneous epileptic seizures. Our findings suggest that developmental morphogen signaling is re-purposed to stabilize cortical networks in the adult mammalian brain.



2:40pm - 3:10pm
ID: 202 / Session 3: 2
Talk

A synaptic mechanism for sculpting neuron activity dynamics within neural circuits

David DiGregorio

University of Colorado Anschutz Medical Campus, USA

Sensations, thoughts, and actions are dynamic events that require the brain to encode the passage of time. For many tasks, such as playing music or sports, accurate execution requires the precise estimation of time intervals in the range of milliseconds to seconds. Nevertheless, how neuronal elements within brain circuits represent “time” is not understood. The cerebellar cortex is a prototypical brain circuit important for fine-tuning precise motor and cognitive behaviors on the subsecond time scale. Synaptic connections between neurons change their strength dynamically during brief bouts of activity, and we hypothesize that they could, therefore, act as a cellular substrate for encoding time within neural networks. I will summarize the theoretical underpinning of how diverse short-term synaptic plasticity can act as a substrate for a biological clock and experimental evidence supporting the role of dynamic synapses in sculpting neural dynamics within the cerebellum.



3:10pm - 3:30pm
ID: 121 / Session 3: 3
Talk

A bistable inhibitory OptoGPCR for multiplexed optogenetic control of neural circuits

Jonas Wietek1,2,3, Adrianna Nozownik4,5, Mauro Pulin4,6, Inbar Saraf-Sinik1,2, Noa Matosevich7, Raajaram Gowrishankar9,10, Asaf Gat1, Daniela Malan11, Bobbie J. Brown12, Julien Dine1,2,13, Bibi Nusreen Imambocus14, Rivka Levy1,2, Kathrin Sauter4, Anna Litvin1,2, Noa Regev15, Suraj Subramaniam1,2, Khalid Abrera9, Dustin Summarli9, Eva Madeline Goren7,8, Gili Mizrachi1,2, Eyal Bitton1,2, Asaf Benjamin1,2, Bryan A. Copits12, Philipp Sasse11, Benjamin R. Rost16,17, Dietmar Schmitz16,17,18, Michael R. Bruchas9,10,19, Peter Soba14,20, Oren-Suissa Meital1, Nir Yuval7,15,21, J. Simon Wiegert4,22, Ofer Yizhar1,2

1Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel; 2Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel; 3Present address: Neuroscience Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany; 4Center for Molecular Neurobiology, Hamburg, Germany; 5Present address: Paris Brain Institute, Institut du Cerveau (ICM), CNRS UMR 7225, INSERM U1127, Sorbonne Université, Paris, France; 6Present address: Laboratory of Sensory Processing, Brain Mind Institute, Faculty of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland; 7Sagol school of neuroscience, Tel Aviv University, Tel Aviv, Israel; 8Present address: University of Michigan, MI, USA; 9Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA; 10Center for Excellence in the Neurobiology of Addiction, Pain and Emotion, University of Washington, Seattle, WA, USA; 11Institut für Physiologie I, Universität Bonn, Bonn, Germany; 12Washington University Pain Center, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, USA; 13Present address: Boehringer Ingelheim Pharma GmbH & Co. KG; CNS Diseases, Biberach an der Riss, Germany; 14LIMES-Institute, University of Bonn, Bonn, Germany; 15Department of Physiology and Pharmacology, Tel Aviv University, Tel Aviv, Israel; 16German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; 17Neuroscience Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany; 18Neuroscience Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany; 19Department of Pharmacology, University of Washington, Seattle, WA, USA; 20Institute of Physiology and Pathophysiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; 21Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel; 22Present address: MCTN, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany

Information is transmitted between brain regions through the release of neurotransmitters from longrange projecting axons. Understanding how the activity of such long-range connections contributes to behavior requires efficient methods for reversibly manipulating their function. Chemogenetic and optogenetic tools, acting through endogenous G-protein coupled receptor (GPCRs) pathways, can be used to modulate synaptic transmission, but existing tools are limited in sensitivity, spatiotemporal precision, or spectral multiplexing capabilities. Here we systematically evaluated multiple bistable opsins for optogenetic applications and found that the Platynereis dumerilii ciliary opsin (PdCO) is an efficient, versatile, light-activated bistable GPCR that can suppress synaptic transmission in mammalian neurons with high temporal precision in-vivo. PdCO has superior biophysical properties that enable spectral multiplexing with other optogenetic actuators and reporters. We demonstrate that PdCO can be used to conduct reversible loss-of-function experiments in long-range projections of behaving animals, thereby enabling detailed synapse-specific functional circuit mapping.



 
Contact and Legal Notice · Contact Address:
Privacy Statement · Conference: ESM Berlin 2024
Conference Software: ConfTool Pro 2.8.101
© 2001–2024 by Dr. H. Weinreich, Hamburg, Germany